Testosterone MD-Lotion

Phase 3Completed

0 watching 0 views this week📈 Rising

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Hypogonadism

Conditions

Hypogonadism

Trial Timeline

Oct 1, 2008 → Aug 1, 2009

NCT ID

NCT00857454

About Testosterone MD-Lotion

Testosterone MD-Lotion is a phase 3 stage product being developed by Eli Lilly for Hypogonadism. The current trial status is completed. This product is registered under clinical trial identifier NCT00857454. Target conditions include Hypogonadism.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (3)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00857454	Phase 3	Completed	Oct 1, 2008	Aug 1, 2009	Hypogonadism
NCT00702650	Phase 3	Completed	Jun 1, 2008	Jul 1, 2009	Hypogonadism
NCT00857961	Phase 2	Completed	Oct 1, 2007	Jan 1, 2008	Hypogonadism

Competing Products

20 competing products in Hypogonadism

See all competitors

Product	Company	Stage	Hype Score
Topical Testosterone Solution	Eli Lilly	Approved	85
Testosterone Solution + Placebo Solution	Eli Lilly	Phase 3	77
Testosterone MD-Lotion	Eli Lilly	Phase 2	52
Testosterone MD-Lotion	Eli Lilly	Phase 3	77
Testosterone Gel 1.62% + Testosterone Gel 1.62%	AbbVie	Phase 1	33
ABT-SLV176	AbbVie	Phase 3	77
AndroGel® + Placebo	AbbVie	Approved	85
AndroGel 1.62%	AbbVie	Approved	85
Recombinant human luteinizing hormone (r-hLH) + Recombinant human follicle-stimulating hormone (r-hFSH) + Human chorionic gonadotropin (hCG)	Merck	Phase 3	77
Oral testosterone undecanoate (Andriol) + Placebo	Merck	Phase 2	52
Reference: Follitropin alfa + Zoladex	Merck	Phase 1	33
Testosterone + Alendronate + Placebo Alendronate + Placebo Testosterone	Merck	Phase 2	52
Testosterone Enanthate + Finasteride	Merck	Phase 2	52
Testim 1% (testosterone gel) + Placebo	Merck	Phase 2	52
Investigational new drug company code: BGS649 + Placebo	Novartis	Phase 2	52
Test formulation + Reference formulation	Pfizer	Phase 1	32
Testosterone Product	Bayer	Pre-clinical	20
Testosterone undecanoate (TU) - NebidoTM	Bayer	Phase 3	74
Testosterone Undeconate (Nebido-R, BAY86-5037)	Bayer	Pre-clinical	20
Testosterone Undeconate (Nebido, BAY86-5037) + Placebo	Bayer	Approved	82

Other Products from Eli Lilly

Insulin Glargine + Insulin Lispro Premix (mid-mixture and low-mixture)Approved

Olanzapine + PlaceboApproved

exenatide and sitagliptin + exenatide and placeboApproved

Tirzepatide + PlaceboApproved

tadalafilApproved